Structure of SARS-CoV-2 main protease in the apo state.
作者信息
Zhou Xuelan, Zhong Fanglin, Lin Cheng, Hu Xiaohui, Zhang Yan, Xiong Bing, Yin Xiushan, Fu Jinheng, He Wei, Duan Jingjing, Fu Yang, Zhou Huan, McCormick Peter J, Wang Qisheng, Li Jian, Zhang Jin
机构信息
School of Basic Medical Sciences, Nanchang University, Nanchang, 330031, China.
College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China.
出版信息
Sci China Life Sci. 2021 Apr;64(4):656-659. doi: 10.1007/s11427-020-1791-3. Epub 2020 Sep 1.
Abstract
摘要
相似文献
1
Structure of SARS-CoV-2 main protease in the apo state.
Sci China Life Sci. 2021 Apr;64(4):656-659. doi: 10.1007/s11427-020-1791-3. Epub 2020 Sep 1.
2
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
J Recept Signal Transduct Res. 2020 Dec;40(6):605-612. doi: 10.1080/10799893.2020.1772298. Epub 2020 Jun 1.
3
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Molecules. 2020 May 29;25(11):2529. doi: 10.3390/molecules25112529.
4
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Reporter Assay.
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01265-20.
5
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
6
Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
J Proteome Res. 2020 Nov 6;19(11):4678-4689. doi: 10.1021/acs.jproteome.0c00367. Epub 2020 Sep 4.
7
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Med Sci (Paris). 2020 Jun-Jul;36(6-7):555-558. doi: 10.1051/medsci/2020106. Epub 2020 Jun 19.
8
Antiviral Drug Discovery To Address the COVID-19 Pandemic.
mBio. 2020 Sep 25;11(5):e02134-20. doi: 10.1128/mBio.02134-20.
9
Optimization Rules for SARS-CoV-2 M Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.
Viruses. 2020 Aug 26;12(9):942. doi: 10.3390/v12090942.
10
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Science. 2020 Jun 19;368(6497):1331-1335. doi: 10.1126/science.abb4489. Epub 2020 Apr 22.
引用本文的文献
1
Olive Leaf Protein Hydrolysate as a Novel Source of Antimicrobial Peptides: Peptidomic Characterization and In Silico Evaluation.
Molecules. 2025 Aug 14;30(16):3382. doi: 10.3390/molecules30163382.
2
Crystal structures of the 3C proteases from Coxsackievirus B3 and B4.
Acta Crystallogr F Struct Biol Commun. 2024 Aug 1;80(Pt 8):183-190. doi: 10.1107/S2053230X24006915. Epub 2024 Jul 25.
3
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools.
Int J Mol Sci. 2024 Feb 1;25(3):1798. doi: 10.3390/ijms25031798.
4
Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M) using molecular docking and deep learning methods.
Comput Biol Med. 2023 May;157:106785. doi: 10.1016/j.compbiomed.2023.106785. Epub 2023 Mar 11.
5
Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.
Molecules. 2022 Dec 21;28(1):50. doi: 10.3390/molecules28010050.
6
Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran.
Antibiotics (Basel). 2022 Sep 27;11(10):1318. doi: 10.3390/antibiotics11101318.
7
Crystal structure of SARS-CoV 3C-like protease with baicalein.
Biochem Biophys Res Commun. 2022 Jun 30;611:190-194. doi: 10.1016/j.bbrc.2022.04.086. Epub 2022 Apr 22.
8
Crystal structures of human coronavirus NL63 main protease at different pH values.
Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):348-355. doi: 10.1107/S2053230X21009523. Epub 2021 Sep 27.
9
High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.
Chem Sci. 2021 Feb 2;12(13):4889-4907. doi: 10.1039/d1sc00145k.
10
SARS-CoV-2 M: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.
Biomolecules. 2021 Apr 19;11(4):607. doi: 10.3390/biom11040607.
Zotero 插件